Related references
Note: Only part of the references are listed.Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model
Juliana Hofstatter Azambuja et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)
EGCG-Mediated Potential Inhibition of Biofilm Development and Quorum Sensing in Pseudomonas aeruginosa
Suqi Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Paeonol Attenuates Quorum-Sensing Regulated Virulence and Biofilm Formation in Pseudomonas aeruginosa
Dan Yang et al.
FRONTIERS IN MICROBIOLOGY (2021)
Research progress of epigallocatechin-3-gallate (EGCG) on anti-pathogenic microbes and immune regulation activities
Zijuan Zhao et al.
FOOD & FUNCTION (2021)
Quorum sensing system: Target to control the spread of bacterial infections
Erika Kushikawa Saeki et al.
MICROBIAL PATHOGENESIS (2020)
Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of Mycobacterium tuberculosis by Enhancing the Autophagy and Suppressing Bacterial Burden
Ankur Sharma et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Tea polyphenols inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances resistance to Klebsiella pneumoniae infection in Caenorhabditis elegans model
Wugao Liu et al.
MICROBIAL PATHOGENESIS (2020)
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
Katherine L. O'Brien et al.
LANCET (2019)
Roles of interleukin-11 during acute bacterial pneumonia
Katrina E. Traber et al.
PLOS ONE (2019)
Detrimental Effect of Type I IFNs During Acute Lung Infection With Pseudomonas aeruginosa Is Mediated Through the Stimulation of Neutrophil NETosis
Ekaterina Pylaeva et al.
FRONTIERS IN IMMUNOLOGY (2019)
Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia
Emel Sen-Kilic et al.
FRONTIERS IN IMMUNOLOGY (2019)
Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation
Jia Wang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)
Emerging Roles of Inflammasomes in Acute Pneumonia
Sangeetha Ravi Kumar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal
Sinosh Skariyachan et al.
FOLIA MICROBIOLOGICA (2018)
Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri-Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study
Ruo-Xuan Dai et al.
BMC PULMONARY MEDICINE (2018)
The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections-A Systematic Review of the Literature
Alice E. Kizny Gordon et al.
CLINICAL INFECTIOUS DISEASES (2017)
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Maitrayee Chatterjee et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Dynamics of Lung Defense in Pneumonia: Resistance, Resilience, and Remodeling
Lee J. Quinton et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 77 (2015)
Which microbial factors really are important in Pseudomonas aeruginosa infections?
Audrey Crousilles et al.
FUTURE MICROBIOLOGY (2015)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Jasmine Lee et al.
PROTEIN & CELL (2015)
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea
J. Steinmann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition
I-Ta Lee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
Wilhelmina G. Melsen et al.
LANCET INFECTIOUS DISEASES (2013)
A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
Deepak Balasubramanian et al.
NUCLEIC ACIDS RESEARCH (2013)
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Shaan L. Gellatly et al.
PATHOGENS AND DISEASE (2013)
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Jia-xin Ling et al.
ACTA PHARMACOLOGICA SINICA (2012)
The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Pol Nadal Jimenez et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Pseudomonas aeruginosa: all roads lead to resistance
Elena B. M. Breidenstein et al.
TRENDS IN MICROBIOLOGY (2011)
Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis
Narayanan Sriram et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Alan R. Hauser
NATURE REVIEWS MICROBIOLOGY (2009)
Targeting virulence: a new paradigm for antimicrobial therapy
Anne E. Clatworthy et al.
NATURE CHEMICAL BIOLOGY (2007)
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections
James A. Driscoll et al.
DRUGS (2007)
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
E Kipnis et al.
MEDECINE ET MALADIES INFECTIEUSES (2006)
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
V Aloush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pathogen-host interactions in Pseudomonas aeruginosa pneumonia
RT Sadikot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
The role of pyocyanin in Pseudomonas aeruginosa infection
GW Lau et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm
K Sauer et al.
JOURNAL OF BACTERIOLOGY (2002)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
REW Hancock et al.
DRUG RESISTANCE UPDATES (2000)
Share Paper
